Niva Bupa Health Insurance Company Q4 Results: Profit surges 67% to Rs 345 crore
Niva Bupa Health Insurance Company reported a strong financial performance for Q4 FY26, with its profit surging by 67% to ₹345 crore. The company also demonstrated strengthened market presence in the retail health segment, as its market share increased to 10.1% for the full fiscal year, representing a 76 basis point improvement over FY25.
May 08 2026 19:05:00
Niva Bupa Health Insurance Company Ltd - 544286 - Grant Of Stock Options
Niva Bupa Health Insurance Board approved several leadership changes during its meeting. These include the elevation of Mr. Ankur Kharbanda to Executive Director and Deputy CEO, alongside the appointment of two new Non-Executive Directors, Mr. Christopher Patrick Carroll and Ms. Siobhan Djihan Moynihan. The board also noted the resignations of two Non-Executive Directors.
May 08 2026 18:05:00
Niva Bupa Health Insurance Company Ltd - 544286 - Announcement under Regulation 30 (LODR)-Change in Management
Niva Bupa Health Insurance elevated Mr. Ankur Kharbanda from Executive Director and Chief Business Officer to Executive Director and Deputy Chief Executive Officer, effective May 8, 2026. This strengthens the company's top management.
May 08 2026 18:05:00
Niva Bupa Health Insurance Company Ltd - 544286 - Announcement under Regulation 30 (LODR)-Change in Directorate
Niva Bupa Health Insurance elevated Mr. Ankur Kharbanda, currently Executive Director and Chief Business Officer, to Executive Director and Deputy Chief Executive Officer, effective May 08, 2026. He has over two decades of experience in the health insurance sector.
May 08 2026 18:05:00
Niva Bupa Health Insurance Company Ltd - 544286 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Niva Bupa Health reported strong audited financial results for FY26, with Profit After Tax (PAT) increasing 80% to Rs.366 crore and Gross Written Premium (GWP) up 27% YoY to Rs.9,433 crore. The company also improved its market share to 10.1% and saw an improvement in its Combined Insurance Service Ratio (CISR).
May 08 2026 17:05:00
Niva Bupa Health Insurance Company Ltd - 544286 - Audited IFRS Financial Statements For The Financial Year Ended March 31, 2026
Niva Bupa announced Q4 FY26 results with gross written premiums up 38.53% YoY to Rs. 2,879.68 cr and profit up 67.47% YoY to Rs. 345.13 cr. The combined ratio improved to 86.12%, while full-year profit declined by 38.75%.
May 08 2026 17:05:00
Niva Bupa Health Insurance Company Ltd - 544286 - Board Meeting Outcome for Audited Financial Results For The Quarter And Financial Year Ended March 31, 2026
Niva Bupa Health Insurance approved its audited Q4 FY26 and FY26 financial results. The company reported a net profit of ₹34.51 crore for Q4 FY26 and ₹13.08 crore for FY26, with a 26.97% growth in gross direct premium for the year. Joint Statutory Auditors issued an unmodified audit opinion.
May 08 2026 17:05:00
Niva Bupa Health Insurance Company Limited
Niva Bupa Health Insurance's Board of Directors will hold a meeting on May 8, 2026, to consider and approve the audited financial results for the quarter and financial year ended March 31, 2026, along with audited IFRS statements.
Apr 30 2026 18:04:00
Niva Bupa Health Insurance Company Ltd - 544286 - Board Meeting Intimation for Consideration And Approval Of The Financial Results For The Quarter And Year Ended March 31, 2026
Niva Bupa Health Insurance Board will convene on May 08, 2026. The meeting agenda includes the consideration and approval of the audited financial results for Q4 and the full financial year ended March 31, 2026.
Apr 30 2026 18:04:00
Niva Bupa Health Insurance Company Limited
Niva Bupa Health's Board of Directors is scheduled to meet on May 08, 2026, to review and approve the audited financial results for the quarter and financial year ended March 31, 2026. The meeting will also cover audited IFRS financial statements.
Apr 30 2026 18:04:00
Read More